Commonwealth Equity Services’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,637
| Closed | -$102K | – | 4095 |
|
|
2024
Q2 | $102K | Sell |
7,637
-1,905
| -20% | -$25.4K | ﹤0.01% | 3810 |
|
|
2024
Q1 | $443K | Buy |
9,542
+94
| +1% | +$4.36K | ﹤0.01% | 2923 |
|
|
2023
Q4 | $639K | Buy |
9,448
+221
| +2% | +$14.9K | ﹤0.01% | 2514 |
|
|
2023
Q3 | $668K | Buy |
9,227
+3,174
| +52% | +$230K | ﹤0.01% | 2346 |
|
|
2023
Q2 | $450K | Buy |
6,053
+1,339
| +28% | +$99.5K | ﹤0.01% | 2714 |
|
|
2023
Q1 | $250 | Buy |
4,714
+575
| +14% | +$30 | ﹤0.01% | 3119 |
|
|
2022
Q4 | $279K | Sell |
4,139
-285
| -6% | -$19.2K | ﹤0.01% | 2927 |
|
|
2022
Q3 | $552K | Buy |
4,424
+932
| +27% | +$116K | ﹤0.01% | 2323 |
|
|
2022
Q2 | $332K | Buy |
3,492
+1,100
| +46% | +$105K | ﹤0.01% | 2745 |
|
|
2022
Q1 | $385K | Buy |
2,392
+645
| +37% | +$104K | ﹤0.01% | 2747 |
|
|
2021
Q4 | $580K | Sell |
1,747
-176
| -9% | -$58.4K | ﹤0.01% | 2403 |
|
|
2021
Q3 | $891K | Buy |
+1,923
| New | +$891K | ﹤0.01% | 2011 |
|